Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Allogene Therapeutics
Business Segments
Business Segments
Loss before income taxes
Loss before income taxes
Allogene Therapeutics
·
Business Segments
·
1 segment
·
Rolls up to
Pre-Tax Income
Breakdown
Segments
Business Segments
View metric
Annual
Segment
FY'24
FY'25
Business Segments
-$257.15M
-$190.89M
Total
-$257.15M
-$190.89M
All segment values are derived from annual filings.